scholarly article | Q13442814 |
P2093 | author name string | Margos G | |
Thomas AW | |||
Mitchell GH | |||
Dluzewski AR | |||
Bannister LH | |||
P2860 | cites work | Integral membrane protein located in the apical complex of Plasmodium falciparum | Q24633619 |
Independent translocation of two micronemal proteins in developing Plasmodium falciparum merozoites | Q27973516 | ||
The pathogenic basis of malaria | Q29615020 | ||
Phage-displayed peptides bind to the malarial protein apical membrane antigen-1 and inhibit the merozoite invasion of host erythrocytes. | Q30863749 | ||
Structure and invasive behaviour ofPlasmodium knowlesimerozoitesin vitro | Q31060680 | ||
A family of erythrocyte binding proteins of malaria parasites | Q33198214 | ||
Motile systems in malaria merozoites: how is the red blood cell invaded? | Q33927258 | ||
The Duffy receptor family of Plasmodium knowlesi is located within the micronemes of invasive malaria merozoites | Q33941679 | ||
Immunization with parasite-derived apical membrane antigen 1 or passive immunization with a specific monoclonal antibody protects BALB/c mice against lethal Plasmodium yoelii yoelii YM blood-stage infection | Q34004431 | ||
Purification, characterization, and immunogenicity of the refolded ectodomain of the Plasmodium falciparum apical membrane antigen 1 expressed in Escherichia coli | Q34122492 | ||
A merozoite receptor protein from Plasmodium knowlesi is highly conserved and distributed throughout Plasmodium | Q34235930 | ||
Progress and challenges for malaria vaccines | Q34521010 | ||
The ins, outs and roundabouts of malaria | Q35134458 | ||
Interaction between cytochalasin B-treated malarial parasites and erythrocytes. Attachment and junction formation | Q36341089 | ||
Mapping regions containing binding residues within functional domains of Plasmodium vivax and Plasmodium knowlesi erythrocyte-binding proteins. | Q36707751 | ||
Invasion of erythrocytes by malaria merozoites | Q36734821 | ||
Malaria parasite invasion: interactions with the red cell membrane | Q39557743 | ||
Erythrocyte entry by malarial parasites. A moving junction between erythrocyte and parasite | Q39600996 | ||
Aspects of immunity for the AMA-1 family of molecules in humans and non-human primates malarias | Q40416071 | ||
Sixty-six kilodalton-related antigens of Plasmodium knowlesi are merozoite surface antigens associated with the apical prominence | Q43872739 | ||
Studies on the structure and invasive behaviour of merozoites of Plasmodium knowlesi | Q43999589 | ||
Actomyosin motor in the merozoite of the malaria parasite, Plasmodium falciparum: implications for red cell invasion. | Q47832139 | ||
Plasmodium falciparum AMA-1 erythrocyte binding peptides implicate AMA-1 as erythrocyte binding protein | Q47872702 | ||
Apical membrane antigen 1 plays a central role in erythrocyte invasion by Plasmodium species | Q47874885 | ||
Proteolytic processing and primary structure of Plasmodium falciparum apical membrane antigen-1. | Q47884690 | ||
Longitudinal study of natural immune responses to the Plasmodium falciparum apical membrane antigen (AMA-1) in a holoendemic region of malaria in western Kenya: Asembo Bay Cohort Project VIII. | Q47888403 | ||
Erythrocyte-binding activity of Plasmodium yoelii apical membrane antigen-1 expressed on the surface of transfected COS-7 cells | Q47889644 | ||
Vaccination trials in rhesus monkeys with a minor, invariant, Plasmodium knowlesi 66 kD merozoite antigen | Q47909837 | ||
Identification, expression, and functional characterization of MAEBL, a sporozoite and asexual blood stage chimeric erythrocyte-binding protein of Plasmodium falciparum | Q47910034 | ||
Structure and development of the surface coat of erythrocytic merozoites of Plasmodium knowlesi | Q47924398 | ||
The Fab fragments of monoclonal IgG to a merozoite surface antigen inhibit Plasmodium knowlesi invasion of erythrocytes | Q47983326 | ||
Biosynthesis of a putative protective Plasmodium knowlesi merozoite antigen | Q47985938 | ||
Plasmodium knowlesi: studies on invasion of rhesus erythrocytes by merozoites in the presence of protease inhibitors | Q47988661 | ||
Protective immunity induced in squirrel monkeys with recombinant apical membrane antigen-1 of Plasmodium fragile. | Q48005602 | ||
Differential localization of full-length and processed forms of PF83/AMA-1 an apical membrane antigen of Plasmodium falciparum merozoites. | Q48006353 | ||
The fine structure of secretion by Plasmodium knowlesi merozoites during red cell invasion | Q56380187 | ||
Rat monoclonal antibodies which inhibit the in vitro multiplication of Plasmodium knowlesi | Q56381024 | ||
Secretion of micronemal proteins is associated with toxoplasma invasion of host cells | Q73510453 | ||
Plasmodium falciparum apical membrane antigen 1 (PfAMA-1) is translocated within micronemes along subpellicular microtubules during merozoite development | Q73764830 | ||
P433 | issue | 1 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | malaria | Q12156 |
merozoite | Q2296434 | ||
malaria vaccine | Q6741353 | ||
P304 | page(s) | 154-158 | |
P577 | publication date | 2004-01-01 | |
P1433 | published in | Infection and Immunity | Q6029193 |
P1476 | title | Apical membrane antigen 1, a major malaria vaccine candidate, mediates the close attachment of invasive merozoites to host red blood cells | |
P478 | volume | 72 |
Q36710710 | A diversity-covering approach to immunization with Plasmodium falciparum apical membrane antigen 1 induces broader allelic recognition and growth inhibition responses in rabbits |
Q47948366 | A recombinant vaccine based on domain II of Plasmodium vivax Apical Membrane Antigen 1 induces high antibody titres in mice. |
Q36625367 | A review of human vaccine research and development: malaria |
Q39189734 | ABO blood group phenotypes and Plasmodium falciparum malaria: unlocking a pivotal mechanism. |
Q36550447 | Acquired immune responses to three malaria vaccine candidates and their relationship to invasion inhibition in two populations naturally exposed to malaria |
Q43986541 | Adenovectors induce functional antibodies capable of potent inhibition of blood stage malaria parasite growth |
Q47923410 | Administration of naloxone in combination with recombinant Plasmodium vivax AMA-1 in BALB/c mice induces mixed Th1/Th2 immune responses |
Q34145333 | Advances and challenges in malaria vaccine development. |
Q33558449 | Allele specificity of naturally acquired antibody responses against Plasmodium falciparum apical membrane antigen 1. |
Q33402457 | An inhibitory antibody blocks interactions between components of the malarial invasion machinery |
Q37455373 | Analysis of Pvama1 genes from China-Myanmar border reveals little regional genetic differentiation of Plasmodium vivax populations |
Q37256085 | Anti-apical-membrane-antigen-1 antibody is more effective than anti-42-kilodalton-merozoite-surface-protein-1 antibody in inhibiting plasmodium falciparum growth, as determined by the in vitro growth inhibition assay |
Q27973517 | Apical membrane antigen 1 mediates apicomplexan parasite attachment but is dispensable for host cell invasion |
Q37410331 | Babesia divergens apical membrane antigen 1 and its interaction with the human red blood cell. |
Q38033589 | Basigin: a multifunctional membrane protein with an emerging role in infections by malaria parasites |
Q33223740 | Binding hot spot for invasion inhibitory molecules on Plasmodium falciparum apical membrane antigen 1 |
Q30503482 | Binding of Plasmodium merozoite proteins RON2 and AMA1 triggers commitment to invasion |
Q37253541 | Cell-mediated immunity elicited by the blood stage malaria vaccine apical membrane antigen 1 in Malian adults: results of a Phase I randomized trial |
Q36862490 | Cohort study of the association of antibody levels to AMA1, MSP119, MSP3 and GLURP with protection from clinical malaria in Ghanaian children |
Q37459461 | Comparison of biological activity of human anti-apical membrane antigen-1 antibodies induced by natural infection and vaccination |
Q33938442 | Conditional expression of Toxoplasma gondii apical membrane antigen-1 (TgAMA1) demonstrates that TgAMA1 plays a critical role in host cell invasion |
Q27230092 | Conditional expression of apical membrane antigen 1 in Plasmodium falciparum shows it is required for erythrocyte invasion by merozoites |
Q35606847 | Crystal structure of Plasmodium knowlesi apical membrane antigen 1 and its complex with an invasion-inhibitory monoclonal antibody |
Q35651429 | Design and evaluation of antimalarial peptides derived from prediction of short linear motifs in proteins related to erythrocyte invasion |
Q33939788 | Development of fluorescent Plasmodium falciparum for in vitro growth inhibition assays |
Q48013866 | Distinct mechanisms govern proteolytic shedding of a key invasion protein in apicomplexan pathogens |
Q33400318 | Distinct roles of Plasmodium rhomboid 1 in parasite development and malaria pathogenesis |
Q42913357 | Enhanced protection against malaria by a chimeric merozoite surface protein vaccine |
Q28474820 | Export of a Toxoplasma gondii rhoptry neck protein complex at the host cell membrane to form the moving junction during invasion |
Q36531224 | Expression of a type B RIFIN in Plasmodium falciparum merozoites and gametes |
Q37737126 | Family members stick together: multi-protein complexes of malaria parasites |
Q48037113 | Fine mapping of an epitope recognized by an invasion-inhibitory monoclonal antibody on the malaria vaccine candidate apical membrane antigen 1. |
Q37887281 | Focus on the ringleader: the role of AMA1 in apicomplexan invasion and replication. |
Q27317456 | Functional analysis of the leading malaria vaccine candidate AMA-1 reveals an essential role for the cytoplasmic domain in the invasion process |
Q37313879 | Genetic diversity and malaria vaccine design, testing and efficacy: preventing and overcoming 'vaccine resistant malaria'. |
Q37348151 | Genetic diversity of the Plasmodium falciparum apical membrane antigen I gene in parasite population from the China-Myanmar border area |
Q35037036 | Global Population Structure of the Genes Encoding the Malaria Vaccine Candidate, Plasmodium vivax Apical Membrane Antigen 1 (PvAMA1). |
Q35260670 | Host cell invasion by apicomplexan parasites: the junction conundrum |
Q30942598 | Humoral immune response to mixed PfAMA1 alleles; multivalent PfAMA1 vaccines induce broad specificity |
Q28727698 | Humoral immune responses to a single allele PfAMA1 vaccine in healthy malaria-naïve adults |
Q33361102 | Identification and characterization of the Plasmodium yoelii PyP140/RON4 protein, an orthologue of Toxoplasma gondii RON4, whose cysteine-rich domain does not protect against lethal parasite challenge infection |
Q28478668 | Identification of a highly antigenic linear B cell epitope within Plasmodium vivax apical membrane antigen 1 (AMA-1) |
Q24814719 | Identification of the moving junction complex of Toxoplasma gondii: a collaboration between distinct secretory organelles |
Q37264651 | Immunization with apical membrane antigen 1 confers sterile infection-blocking immunity against Plasmodium sporozoite challenge in a rodent model. |
Q33302903 | Impact of a Plasmodium falciparum AMA1 vaccine on antibody responses in adult Malians |
Q90195758 | Importance of Erythrocyte Deformability for the Alignment of Malaria Parasite upon Invasion |
Q36314049 | In immunization with Plasmodium falciparum apical membrane antigen 1, the specificity of antibodies depends on the species immunized |
Q37643881 | Inside scoop on outside proteins |
Q33825130 | Interaction between Plasmodium falciparum apical membrane antigen 1 and the rhoptry neck protein complex defines a key step in the erythrocyte invasion process of malaria parasites |
Q30043432 | Intramembrane proteolysis mediates shedding of a key adhesin during erythrocyte invasion by the malaria parasite |
Q34287125 | Membrane-wrapping contributions to malaria parasite invasion of the human erythrocyte |
Q80113199 | Mimetic membrane system to carry multiple antigenic proteins from Leishmania amazonensis |
Q33261308 | Mimotopes of apical membrane antigen 1: Structures of phage-derived peptides recognized by the inhibitory monoclonal antibody 4G2dc1 and design of a more active analogue |
Q42727356 | Mode of action of invasion-inhibitory antibodies directed against apical membrane antigen 1 of Plasmodium falciparum |
Q47828966 | Molecular determinants for subcellular trafficking of the malarial sheddase PfSUB2. |
Q24811597 | Molecular identification of a malaria merozoite surface sheddase |
Q36289035 | Mononeme: a new secretory organelle in Plasmodium falciparum merozoites identified by localization of rhomboid-1 protease |
Q90166221 | Natural selection and genetic diversity of domain I of Plasmodium falciparum apical membrane antigen-1 on Bioko Island |
Q38065630 | New approaches to studying Plasmodium falciparum merozoite invasion and insights into invasion biology |
Q33939405 | Non-apical membrane antigen 1 (AMA1) IgGs from Malian children interfere with functional activity of AMA1 IgGs as judged by growth inhibition assay |
Q37253798 | Not a Simple Tether: Binding of Toxoplasma gondii AMA1 to RON2 during Invasion Protects AMA1 from Rhomboid-Mediated Cleavage and Leads to Dephosphorylation of Its Cytosolic Tail |
Q27972792 | Novel putative glycosylphosphatidylinositol-anchored micronemal antigen of Plasmodium falciparum that binds to erythrocytes |
Q35073867 | Passive immunization with a multicomponent vaccine against conserved domains of apical membrane antigen 1 and 235-kilodalton rhoptry proteins protects mice against Plasmodium yoelii blood-stage challenge infection. |
Q33788027 | Peptide inhibitors of the malaria surface protein, apical membrane antigen 1: identification of key binding residues |
Q33788306 | Phase 1 clinical trial of apical membrane antigen 1: an asexual blood-stage vaccine for Plasmodium falciparum malaria |
Q33434412 | Phase 1/2a study of the malaria vaccine candidate apical membrane antigen-1 (AMA-1) administered in adjuvant system AS01B or AS02A. |
Q27972559 | Plasmodium falciparum AMA1 binds a rhoptry neck protein homologous to TgRON4, a component of the moving junction in Toxoplasma gondii |
Q37349074 | Plasmodium falciparum apical membrane antigen 1 vaccine elicits multifunctional CD4 cytokine-producing and memory T cells |
Q21131363 | Plasmodium falciparum erythrocyte invasion: combining function with immune evasion |
Q37188081 | Plasmodium in the postgenomic era: new insights into the molecular cell biology of malaria parasites. |
Q37301136 | Plasmodium sporozoite-host interactions from the dermis to the hepatocyte |
Q41566130 | Plasmodium vivax ligand-receptor interaction: PvAMA-1 domain I contains the minimal regions for specific interaction with CD71+ reticulocytes. |
Q36671923 | Polymorphism at the apical membrane antigen 1 locus reflects the world population history of Plasmodium vivax |
Q49294375 | Population genetic structure and natural selection of Plasmodium falciparum apical membrane antigen-1 in Myanmar isolates |
Q36286806 | Population genetic structure and natural selection of apical membrane antigen-1 in Plasmodium vivax Korean isolates |
Q35875731 | Proteases in host cell invasion by the malaria parasite |
Q27314651 | Protein kinase a dependent phosphorylation of apical membrane antigen 1 plays an important role in erythrocyte invasion by the malaria parasite |
Q27973901 | RON12, a novel Plasmodium-specific rhoptry neck protein important for parasite proliferation |
Q43148430 | Rapid optimization of a peptide inhibitor of malaria parasite invasion by comprehensive N-methyl scanning |
Q38618898 | Recombinant modified vaccinia virus Ankara-based malaria vaccines |
Q33394245 | Safety and immunogenicity of a recombinant Plasmodium falciparum AMA1 malaria vaccine adjuvanted with Alhydrogel, Montanide ISA 720 or AS02. |
Q28742239 | Safety and immunogenicity of multi-antigen AMA1-based vaccines formulated with CoVaccine HTTM and Montanide ISA 51 in rhesus macaques |
Q41501868 | Sequence Analysis of Different Domains of Plasmodium vivax Apical Membrane Antigen (PvAMA-1 gene) Locus in Iran. |
Q33772752 | Solution structure of a Plasmodium falciparum AMA-1/MSP 1 chimeric protein vaccine candidate (PfCP-2.9) for malaria |
Q38393551 | Strain-specific Plasmodium falciparum multifunctional CD4(+) T cell cytokine expression in Malian children immunized with the FMP2.1/AS02A vaccine candidate |
Q33943794 | Structure of AMA1 from Plasmodium falciparum reveals a clustering of polymorphisms that surround a conserved hydrophobic pocket |
Q27648686 | Structure of the Malaria Antigen AMA1 in Complex with a Growth-Inhibitory Antibody |
Q48004710 | Targeted deletion of Plasmodium knowlesi Duffy binding protein confirms its role in junction formation during invasion |
Q33828611 | The C-terminus of Toxoplasma RON2 provides the crucial link between AMA1 and the host-associated invasion complex |
Q38375594 | The apicomplexan glideosome and adhesins - Structures and function |
Q35052721 | The invasion process of bovine erythrocyte by Babesia divergens: knowledge from an in vitro assay |
Q37568142 | The malaria merozoite, forty years on. |
Q27230093 | The transmembrane isoform of Plasmodium falciparum MAEBL is essential for the invasion of Anopheles salivary glands |
Q27972762 | Two Plasmodium rhomboid proteases preferentially cleave different adhesins implicated in all invasive stages of malaria |
Q27024344 | Vaccines for malaria: how close are we? |
Q36227228 | Variation in use of erythrocyte invasion pathways by Plasmodium falciparum mediates evasion of human inhibitory antibodies |
Q33375053 | ama1 genes of sympatric Plasmodium vivax and P. falciparum from Venezuela differ significantly in genetic diversity and recombination frequency |
Search more.